RE-BVS – Piemonte Repository

Sfoglia per AUTORE
BARBERO D
Collezione AOU Alessandria

Items : 7

A Clinical Prognostic Model Based on Machine Learning from the Fondazione Italiana Linfomi (FIL) MCL0208 Phase III Trial. in Cancers / Cancers (Basel). 2021 Dec 31;14(1):188. doi: 10.3390/cancers14010188.

2021
AOU Alessandria
AOU Città della Salute di Torino

Hermine O; Vitolo U; Guarini A; Fabbri A; Patti C; Latte G; Spina M; Pascarella A; Vallisa D; Merli F; Di Renzo N; Cabras MG; Moia R; Volpetti S; Tani M; Del Giudice I; Barbero D; Ghislieri M; Drandi D; Genuardi E; Evangelista A; Passera R; Hoster E; Ferrero S; Zaccaria GM; Kluin-Nelemans HC; Cortelazzo S; Dreyling M; Ladetto M; et alii...

KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. in Haematologica / Haematologica. 2020 Jun;105(6):1604-1612. doi: 10.3324/haematol.2018.214056. Epub 2019 Sep 19.

2020
AOU Alessandria
AOU Città della Salute di Torino

Bertoni F; Ladetto M; Cortelazzo S; Piccin A; Grønbæk K; Ferreri A; Santoro A; Molinari A; da Silva MG; Zamò A; Jerkeman M; Paulli M; Novero D; Kolstad A; Barbero D; Schipani M; Mahmoud AM; Ghione P; Favini C; Stefoni V; Diop F; Dahl C; Di Rocco A; Kwee I; Moia R; Evangelista A; Spina V; Eskelund CW; Bruscaggin A; et alii...

Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma. in Hematological oncology / Hematol Oncol. 2020 Dec;38(5):698-704. doi: 10.1002/hon.2792. Epub 2020 Aug 28.

2020
AOU Alessandria
AOU Città della Salute di Torino

Ladetto M; Ferrero S; Foà R; Guarini A; Cortelazzo S; Martelli M; Galimberti S; Di Rocco A; Gattei V; Degan M; Grassi S; Bomben R; Ciabatti E; Monitillo L; Barbero D; Ferrante M; Drandi D; Mantoan B; Genuardi E; Soscia R; Novelli N; Cavalli M; De Novi LA; Della Starza I; Del Giudice I;

Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network. in Hematological oncology / Hematol Oncol. 2019 Oct;37(4):368-374. doi: 10.1002/hon.2652. Epub 2019 Aug 16.

2019
AOU Alessandria

Della Starza I; Cavalli M; De Novi LA; Genuardi E; Mantoan B; Drandi D; Barbero D; Ciabatti E; Grassi S; Gazzola A; Mannu C; Agostinelli C; Piccaluga PP; Bomben R; Degan M; Gattei V; Guarini A; Foà R; Galimberti S; Ladetto M; Ferrero S; Del Giudice I;

Applying Data Warehousing to a Phase III Clinical Trial From the Fondazione Italiana Linfomi Ensures Superior Data Quality and Improved Assessment of Clinical Outcomes. in JCO clinical cancer informatics / JCO Clin Cancer Inform. 2019 Oct;3:1-15. doi: 10.1200/CCI.19.00049.

2019
AOU Alessandria
AOU Città della Salute di Torino

Omedè P; Ferreri A; Molinari AL; Ballerini F; Arcaini L; Lo Schirico M; Castagneri C; Barbero D; Sandrone R; Evangelista A; Genuardi E; Ghislieri M; Rosati S; Zaccaria GM; Ferrero S; Zamò A; Balestra G; Boccadoro M; Cortelazzo S; Ladetto M;

Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: evidences from long term follow-up. in British journal of haematology / Br J Haematol. 2018 Jun;181(5):693-695. doi: 10.1111/bjh.14681. Epub 2017 Apr 2.

2018
AOU Alessandria

Ghione P; Genuardi E; Rossi D; Drandi D; Mantoan B; Barbero D; Bernocco E; Monitillo L; Cerri M; Ruggeri M; Omede P; Deambrogi C; De Paoli L; Passera R; Coscia M; Cavallo F; Massaia M; Boccadoro M; Gaidano G; Ladetto M; Ferrero S;

Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis. in International journal of laboratory hematology / Int J Lab Hematol. 2018 Apr;40(2):201-208. doi: 10.1111/ijlh.12766. Epub 2017 Dec 4.

2018
AOU Alessandria

Genuardi E; Barbero D; Dogliotti I; Mantoan B; Drandi D; Gambella M; Zaccaria GM; Monitillo L; Della Starza I; Cavalli M; De Novi LA; Ciabatti E; Grassi S; Gazzola A; Mannu C; Del Giudice I; Galimberti S; Agostinelli C; Piccaluga PP; Ladetto M; Ferrero S;